Gene.: auth.: group Reymond

Gene. 2020 May 27;144816.


Hemizygosity of the MIR17HG gene encoding the miR-17∼92 cluster is associated with Feingold syndrome 2 characterized by intellectual disability, skeletal abnormalities, short stature and microcephaly. Here, we report on a female with a de novo 13q31.3 microduplication encompassing MIR17HG but excluding GPC5. She presented developmental delay, skeletal and digital abnormalities, and features such as tall stature and macrocephaly mirroring those of Feingold syndrome 2 patients. The limited extent of the proband’s rearrangement to the miR cluster and the corresponding normal expression level of the neighboring GPC5 in her cells, together with previously described data on affected individuals of two families carrying overlapping duplications of the miR-17∼92 cluster that comprise part of GPC5, who likewise presented macrocephaly, developmental delay, as well as skeletal, digital and stature abnormalities, allow to define a new syndrome due to independent microduplication of the miR-17∼92 cluster.

Keywords: 13q31.3 microduplication; Feingold syndrome 2; GPC5; MIR17HG; miR-17∼92 cluster; qPCR.